Patents Assigned to Galimedix Therapeutics, Inc.
  • CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF
    Publication number: 20230242483
    Abstract: The invention provides crystalline forms of solvates of tryptophan derivatives of compound (1), compositions comprising them, processes for their preparations and methods of use thereof.
    Type: Application
    Filed: May 23, 2021
    Publication date: August 3, 2023
    Applicant: Galimedix Therapeutics Inc.
    Inventors: Jozsef Jozsef REPASI REPASI, Andras SZABO, Hermann Kurt RUSS, Markus HENRICH
  • NOVEL POLYMORPH FORM OF (R)-2-[2-AMINO-3-(INDOL-3-YL)PROPIONYLAMINO]-2-METHYLPROPIONIC ACID AND USES THEREOF
    Publication number: 20220389056
    Abstract: This intention relates to a novel polymorph form of compound (R)-2-[2-amino-3-(indol-3-yl)propionylamino]-2-methylpropionic acid, a process for making the novel polymorph form of the compound, and uses thereof for making other polymorph forms of the compound. The invention further relates to composition comprising novel polymorph form of the compound and a pharmaceutically acceptable carrier or excipient.
    Type: Application
    Filed: September 23, 2020
    Publication date: December 8, 2022
    Applicant: Galimedix Therapeutics Inc.
    Inventors: Jozsef REPASI, Andras SZABO, Markus HENRICH
  • INDOLE COMPOUNDS FOR USE IN NEURORESTORATION
    Publication number: 20220193035
    Abstract: Provided herein are methods of use of indole derivative compounds for reversal of amyloid ? toxicity in amyloid ?-associated diseases.
    Type: Application
    Filed: April 23, 2020
    Publication date: June 23, 2022
    Applicant: Galimedix Therapeutics, Inc.
    Inventors: Christopher Graham Raphael. Parsons (Deceased), Gerhard Rammes, Hermann Russ, Andrew L Pearlman